In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
The high-throughput system enables laboratories to double or even triple their testing capacity
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Catch up on this expert on-demand webinar to discover a novel approach for in silico method development and robustness assessment
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
BLENREP is the fifth major medicine approval for GSK in 2020
Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Easy-to-use molecular biology test delivers results in less than one hour
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
The analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process
Exclusive interviews, new methods, free downloads and much more to help advance your biopharmaceutical research
Find out how collaboration between Pall and key life sciences researchers is helping to innovate and accelerate biologic development
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
Download this free eBook today to streamline development and accelerate time-to-market
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
